Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.
Wade
Alan G
AG
CPS Clinical Research Centre, Glasgow, UK. alangwade@fastmail.fm
Saragoussi
Delphine
D
Despiégel
Nicolas
N
François
Clément
C
Guelfucci
Florent
F
Toumi
Mondher
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D015283:Citalopram / Q000191:economics / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000191:economics / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000191:economics; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use*; D005260:Female; D017048:Health Care Costs; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D017367:Selective Serotonin Reuptake Inhibitors / Q000191:economics / Q000627:therapeutic use*; D012720:Severity of Illness Index; D006113:United Kingdom; D000069470:Venlafaxine Hydrochloride; D055815:Young Adult
D015283:Citalopram; D003511:Cyclohexanols; D016568:Drugs, Generic; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride